In a world first, youngest child undergoes own cord blood reinfusion to determine potential to prevent or delay onset of Type 1 Diabetes

In a world first, youngest child undergoes own cord blood reinfusion to determine potential to prevent or delay onset of Type 1 Diabetes

As part of The CORD study (Cord Reinfusion in Diabetes), Lucy, a 20 month old Australian girl, was reinfused with her own umbilical cord blood to determine whether it will delay or prevent the onset of type 1 diabetes. The study is being conducted through the Kids...
Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)

Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)

Research Update- AML Trial ExCellThera is a clinical stage biotech company that is focused on developing a robust and cost effective technology to expand blood stem cells from cord blood for therapeutic use. ExCellThera is a spin-off company from the Institute for...
add chat to your website

Get Info Pack

Take the first step to learn about cord blood and cord tissue banking today!

EXCLUSIVE CORD BLOOD OFFER

Receive a FREE mamaRoo when you enroll to store cord blood & tissue OR a FREE rockaRoo when you enroll to store cord blood

Copy Promo Code:
'MAMAROO' for Cord Blood & Tissue
'ROCKAROO" for Cord Blood Only
ENROLL NOW
Copy Promo Code Before You Enroll
Offer ends November 10, 2019
close-link
Blog Clinical Trials